No Data
No Data
Mebuki FG, Yonex ETC (additional) Rating
Upgraded - Bullish Code Stock Name Securities Company Previous Changed to ----------------------------------------------------------- <2607> Fuji Oil Morgan Stanley "Equal Weight" "Over Weight" <4502> Takeda Morgan Stanley "Equal Weight" "Over Weight" Downgraded - Bearish Code Stock Name Securities Company Previous Changed to -------------------------------------------
Hirata Corporation - "Factory that creates factories" for manufacturing equipment for major manufacturers worldwide, attention on the growth strategy and Shareholder return policy of the next medium-term plan.
Hirata Corporation <6258> is a company that provides production equipment in various industries such as Autos, Semiconductors, and home appliances, referred to as a "factory that builds factories." Since its establishment in 1951, it has consistently contributed to the automation and efficiency of production lines for major manufacturers both domestically and internationally, with its strength lying in the know-how cultivated through diverse production equipment manufacturing and a consistent system that can handle everything from development to production and maintenance in one company. In the fiscal year ending March 2024, the revenue composition ratio by segment is related to Autos.
Rating [Securities companies rating]
Rating Upgrade - Bullish Code Stock Name Brokerage Firm Previous Change After ---------------------------------------------------------------- <6506> Yaskawa Electric Morgan Stanley "Equal Weight" "Overweight" <6301> Komatsu Goldman "Sell" "Hold" <5333> NGK Insulators Goldman "Sell" "Hold" <8967> Nihon Logistics Daiwa "2" "1" <9603> H.I.S. Iwai Cosmo "B"
Express News | According to Bloomberg, SoftBank Group is seeking a loan of up to 16.5 billion USD to fund its AI investments in the USA, which would be the company's largest pure dollar loan ever. Insiders say that the bridge loan being discussed has a term of approxima
Rakuoria Pharma - rebound, received a one-time payment from ASTELLAS PHARMA.
A rebound occurred. After the close of trading on March 31, it was announced that the subsidiary, FIMEX, received a lump sum payment from ASTELLAS PHARMA for achieving the next stage of initial goals in a joint research project. This news was positively received. In relation to this matter, FIMEX will receive 0.2 billion yen from ASTELLAS PHARMA, which will be recorded as business revenue for the first quarter of the fiscal year ending December 25. If a new Pharmaceutical product is commercialized, a milestone payment of up to over 15 billion yen will be received based on progress.
Strong performance, with an upward trend in the Dow Inc average leading to dominance in buying on dips.
[Emerging Markets Individual Stocks Global Strategy] Today's Emerging Markets are expected to show a stable development. On March 31, the US Stocks market saw the Dow Inc rise by 417.86 points (+1.00%) to 42,001.76, rebounding for the first time in four days. Caution over Trump's tariffs and the diminishing expectations of a ceasefire between Russia and Ukraine weighed on stock prices. On the other hand, the unexpected rise in the Chicago Purchasing Managers' Index and the month-end and quarter-end 'dressing buys' supported the market. Today's Emerging Markets are favorable for Buy.